Ridgetech, Inc.
$2.21
▼
-11.51%
2026-04-21 09:05:01
www.ridgetch.com
NCM: RDGT
Explore Ridgetech, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2 M
Current Price
$2.21
52W High / Low
$760.5 / $2.01
Stock P/E
0.16
Book Value
$5.09
Dividend Yield
—
ROCE
-3.44%
ROE
-8.02%
Face Value
—
EPS
$-54.61
Exp Qtr EPS
—
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
61
Beta
0.18
Debt / Equity
15.65
Current Ratio
1.82
Quick Ratio
1.45
Forward P/E
—
Price / Sales
0.02
Enterprise Value
$-9.18 M
EV / EBITDA
10.59
EV / Revenue
-0.08
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Wellgistics Health, Inc. | $0.13 | — | $17.59 M | — | -11952.35% | 3545.19% | $7.04 / $0.1 | $-0.12 |
| 2. | Scienture Holdings, Inc. | $0.42 | — | $16.97 M | 12.89% | -19.95% | -55.65% | $2.6 / $0.24 | $1.73 |
| 3. | Cellyan Biotechnology Co., Ltd | $0.73 | — | $8.03 M | — | 3.09% | -13.38% | $2.76 / $0.37 | $0.47 |
| 4. | High Tide Inc. | $2.47 | — | $288.3 M | — | 6.2% | -39.72% | $5.59 / $2.85 | $0.72 |
| 5. | Gilead Sciences, Inc. | $133.45 | 19.68 | $165.41 B | 2.41% | 24.79% | 40.66% | $157.29 / $93.37 | $18.29 |
| 6. | Marvell Technology, Inc. | $154.81 | 50.34 | $134.52 B | 0.16% | 7.02% | 19.25% | $149.58 / $48.09 | $16.89 |
| 7. | Thermo Fisher Scientific Inc. | $521.21 | 29.42 | $194.29 B | 0.36% | 8.52% | 13.02% | $643.99 / $385.46 | $141.96 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 119.97 M | 123.99 M | 120.2 M | 164.39 M |
| Operating Profit | -1.04 M | 0.6 M | -13.16 M | -2.55 M |
| Net Profit | 10.19 M | -4.23 M | -21.14 M | -3.19 M |
| EPS in Rs | 11.34 | -4.71 | -23.52 | -3.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 64.48 M | 95.06 M | 90.97 M | 106.38 M |
| Total Liabilities | 34.85 M | 80.76 M | 74.3 M | 83.65 M |
| Equity | 29.64 M | 15.64 M | 18.01 M | 24.09 M |
| Current Assets | 59.71 M | 69.68 M | 64.48 M | 75.36 M |
| Current Liabilities | 34.36 M | 74.36 M | 66.54 M | 74.45 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.25 M | -3.16 M | -3.28 M | -5.39 M |
| Investing CF | -18.14 M | -2.04 M | -0.32 M | -0.31 M |
| Financing CF | 1.51 M | 8 M | 2.37 M | 4.84 M |
| Free CF | 0.63 M | -4.08 M | -3.6 M | -5.69 M |
| Capex | -0.62 M | -0.92 M | -0.31 M | -0.31 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -3.24% | 3.16% | -26.88% | — |
| Earnings Growth % | 340.76% | 79.97% | -562.21% | — |
| Profit Margin % | 8.5% | -3.41% | -17.59% | -1.94% |
| Operating Margin % | -0.86% | 0.48% | -10.95% | -1.55% |
| Gross Margin % | 3.2% | 3.93% | 3% | 22.21% |
| EBITDA Margin % | 4.15% | 4.82% | -10.35% | -0.35% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-04-08 | 1:0.00666667 |
| 2024-03-01 | 1:0.05 |
| 2022-04-07 | 1:0.0833333 |